The article in this week’s edition of New Scientist is an amazing article, which is a summary of the clinical trial of conducted in Australia on both the link between Multiple Sclerosis and the Epstein-Barr virus, the virus responsible for glandular fever. 

More importantly, early trails suggest that T-cell therapy can be a viable treatment for this auto-immune, but severely debilitating disease.

Amazing stuff and a must read.

Want to know more?

If you want more information or would like to book for a FREE full body assessment with one of our Physiotherapists or Exercise Physiologists, call us on 9857 0644 or email us at admin@mdhealth.com.au

MS symptoms improved by treatment that attacks glandular fever virus

MS symptoms improved by treatment that attacks glandular fever virus

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis

Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis. 

Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS characterized by progressive demyelination and disability.

Share This